Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Pro-Dex

Pro-Dex Inc. specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate embedded motion control and miniature rotary drive systems. With operations in Santa Ana, California and Beaverton, Oregon, Pro-Dex designs and produces products serving the medical, dental, factory automation and scientific research markets. The Company's strategic focus is to get customers to market faster, at a lower cost and with a higher quality product. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, scientific research facilities and high tech manufacturing operations around the world. Pro-Dex is a company based on the concept that everything we do should create value, value for our customers, value for our suppliers, value for our employees and value for our shareholders. The Company takes all the individual investments made into the Company, whether investments in time, capital or energy, and turns them into something more than they began. This is our job and our commitment.


Contact Details:
151 E. Columbine Ave.
Santa Ana
CA
92707
United States of America
Tel:(800) 562-6204 or (714) 241-4411
Fax:(714) 513-7755
Email:info@pro-dex.com
WWW:

www.pro-dex.com/




Loading...

Press Releases on Pro-Dex:

BioPortfolio Logo
PRO-DEX, INC. Announces Fiscal First Quarter 2010 Profit, Update on Business Development Activities, and Renewal of Banking Agreement 29th October, 2009 Pro-Dex, Inc.
IRVINE, Calif., Oct. 29 /PRNewswire-FirstCall/ -- PRO-DEX, INC. (Nasdaq: PDEX) today announced its financial results for the fiscal first quarter ending September 30, 2009. In addition, Pro-Dex
Pro-Dex, Inc. Announces Fiscal 2009 Third Quarter Financial Results Conference Call and Webcast 8th May, 2009 Pro-Dex, Inc.
IRVINE, Calif., May 8 /PRNewswire-FirstCall/ -- PRO-DEX, INC. (Nasdaq: PDEX) invites shareholders and investors to listen to a broadcast review of the Company's fiscal 2009 third quarter

BioNews Results for Pro-Dex:

MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apopto
Nature:  Nov 10 2009 10:58AM Matching: pro dex

Pro-Dex (PDEX) Financial information Links from Barchart

PDEX Quote from from Barchart.com
PDEX Chart from from Barchart.com
PDEX Profile from from Barchart.com
PDEX Opinion from from Barchart.com

View more Pro-Dex finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 1157 times since April 2007, the link to the organisation's website has been followed 161 times

Recent Search Terms used to find this page: prodex | pdex shareholder | new drug prodex | prodex | .

Search for more companies in Santa Ana

Search for more companies in CA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Pro-Dex

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.